QQQ   280.53 (-0.41%)
AAPL   140.94 (-1.38%)
MSFT   244.37 (-0.31%)
META   113.93 (-0.17%)
GOOGL   94.94 (-2.10%)
AMZN   88.46 (+0.24%)
TSLA   174.04 (-3.21%)
NVDA   161.20 (+0.83%)
NIO   12.58 (-4.98%)
BABA   88.33 (-3.41%)
AMD   70.14 (-0.19%)
T   19.30 (+0.68%)
MU   53.82 (+0.26%)
CGC   3.24 (-10.25%)
F   13.10 (-1.36%)
GE   85.00 (-0.33%)
DIS   92.15 (-0.15%)
AMC   6.05 (-10.37%)
PYPL   74.42 (+3.03%)
PFE   50.24 (+1.07%)
NFLX   308.42 (+0.94%)
QQQ   280.53 (-0.41%)
AAPL   140.94 (-1.38%)
MSFT   244.37 (-0.31%)
META   113.93 (-0.17%)
GOOGL   94.94 (-2.10%)
AMZN   88.46 (+0.24%)
TSLA   174.04 (-3.21%)
NVDA   161.20 (+0.83%)
NIO   12.58 (-4.98%)
BABA   88.33 (-3.41%)
AMD   70.14 (-0.19%)
T   19.30 (+0.68%)
MU   53.82 (+0.26%)
CGC   3.24 (-10.25%)
F   13.10 (-1.36%)
GE   85.00 (-0.33%)
DIS   92.15 (-0.15%)
AMC   6.05 (-10.37%)
PYPL   74.42 (+3.03%)
PFE   50.24 (+1.07%)
NFLX   308.42 (+0.94%)
QQQ   280.53 (-0.41%)
AAPL   140.94 (-1.38%)
MSFT   244.37 (-0.31%)
META   113.93 (-0.17%)
GOOGL   94.94 (-2.10%)
AMZN   88.46 (+0.24%)
TSLA   174.04 (-3.21%)
NVDA   161.20 (+0.83%)
NIO   12.58 (-4.98%)
BABA   88.33 (-3.41%)
AMD   70.14 (-0.19%)
T   19.30 (+0.68%)
MU   53.82 (+0.26%)
CGC   3.24 (-10.25%)
F   13.10 (-1.36%)
GE   85.00 (-0.33%)
DIS   92.15 (-0.15%)
AMC   6.05 (-10.37%)
PYPL   74.42 (+3.03%)
PFE   50.24 (+1.07%)
NFLX   308.42 (+0.94%)
QQQ   280.53 (-0.41%)
AAPL   140.94 (-1.38%)
MSFT   244.37 (-0.31%)
META   113.93 (-0.17%)
GOOGL   94.94 (-2.10%)
AMZN   88.46 (+0.24%)
TSLA   174.04 (-3.21%)
NVDA   161.20 (+0.83%)
NIO   12.58 (-4.98%)
BABA   88.33 (-3.41%)
AMD   70.14 (-0.19%)
T   19.30 (+0.68%)
MU   53.82 (+0.26%)
CGC   3.24 (-10.25%)
F   13.10 (-1.36%)
GE   85.00 (-0.33%)
DIS   92.15 (-0.15%)
AMC   6.05 (-10.37%)
PYPL   74.42 (+3.03%)
PFE   50.24 (+1.07%)
NFLX   308.42 (+0.94%)
NASDAQ:CTHR

Charles & Colvard, Ltd. - CTHR Stock Forecast, Price & News

$0.88
+0.02 (+2.33%)
(As of 12/7/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.86
$0.90
50-Day Range
$0.86
$1.06
52-Week Range
$0.86
$3.04
Volume
52,517 shs
Average Volume
69,156 shs
Market Capitalization
$26.70 million
P/E Ratio
44.01
Dividend Yield
N/A
Price Target
N/A
CTHR stock logo

About Charles & Colvard, Ltd. (NASDAQ:CTHR) Stock

Charles & Colvard, Ltd. operates as a fine jewelry company in the United States and internationally. The company operates in two segments, Online Channels and Traditional. It manufactures, markets, and distributes moissanite jewels and finished moissanite jewelry under the Charles & Colvard Created Moissanite brand; and premium moissanite gemstones under the Forever One brand name. The company also markets and distributes lab grown diamonds, and finished jewelry with lab grown diamonds under the Caydia brand. It sells its products at wholesale prices to distributors, manufacturers, retailers, and designers; and to end-consumers at retail prices through charlesandcolvard.com and moissaniteoutlet.com, third-party online marketplaces, drop-ship, and other e-commerce outlets. The company was incorporated in 1995 and is headquartered in Morrisville, North Carolina.

Receive CTHR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Charles & Colvard, Ltd. and its competitors with MarketBeat's FREE daily newsletter.

CTHR Stock News Headlines

Charles & Colvard, Ltd. (NASDAQ:CTHR) Now Covered by StockNews.com
See More Headlines
Receive CTHR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Charles & Colvard, Ltd. and its competitors with MarketBeat's FREE daily newsletter.

CTHR Company Calendar

Last Earnings
11/04/2021
Today
12/07/2022
Next Earnings (Estimated)
2/02/2023
Fiscal Year End
6/30/2023

Industry, Sector and Symbol

Industry
Jewelry, silverware, & plated ware
Sub-Industry
N/A
Current Symbol
NASDAQ:CTHR
Employees
51
Year Founded
N/A

Profitability

Net Income
$2.37 million
Pretax Margin
1.86%

Debt

Sales & Book Value

Annual Sales
$43.09 million
Cash Flow
$0.09 per share
Book Value
$1.94 per share

Miscellaneous

Free Float
24,215,000
Market Cap
$26.70 million
Optionable
Not Optionable
Beta
0.52

Key Executives

  • Mr. Don O'Connell (Age 55)
    Pres, CEO & Director
    Comp: $650.01k
  • Mr. Clint J. Pete (Age 60)
    CFO & Treasurer
    Comp: $367.73k
  • Mr. John Lane
    VP of Marketing
  • Mr. Randall N. McCullough (Age 70)
    Advisory Consulting













CTHR Stock - Frequently Asked Questions

How have CTHR shares performed in 2022?

Charles & Colvard, Ltd.'s stock was trading at $2.89 at the beginning of 2022. Since then, CTHR shares have decreased by 69.6% and is now trading at $0.8798.
View the best growth stocks for 2022 here
.

Are investors shorting Charles & Colvard, Ltd.?

Charles & Colvard, Ltd. saw a increase in short interest in November. As of November 15th, there was short interest totaling 31,000 shares, an increase of 56.6% from the October 31st total of 19,800 shares. Based on an average daily volume of 65,800 shares, the days-to-cover ratio is presently 0.5 days. Approximately 0.1% of the company's stock are sold short.
View Charles & Colvard, Ltd.'s Short Interest
.

When is Charles & Colvard, Ltd.'s next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 2nd 2023.
View our CTHR earnings forecast
.

How were Charles & Colvard, Ltd.'s earnings last quarter?

Charles & Colvard, Ltd. (NASDAQ:CTHR) issued its quarterly earnings data on Thursday, November, 4th. The company reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.02 by $0.01. The company earned $10.28 million during the quarter, compared to analysts' expectations of $9.20 million. Charles & Colvard, Ltd. had a net margin of 1.64% and a trailing twelve-month return on equity of 1.12%. During the same period last year, the company earned $0.03 EPS.

What other stocks do shareholders of Charles & Colvard, Ltd. own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Charles & Colvard, Ltd. investors own include Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Golar LNG Partners (GMLP), Novan (NOVN), OrganiGram (OGI), Pennsylvania Real Estate Investment Trust (PEI), Bionano Genomics (BNGO), Gran Tierra Energy (GTE), Zosano Pharma (ZSAN) and Aeterna Zentaris (AEZS).

What is Charles & Colvard, Ltd.'s stock symbol?

Charles & Colvard, Ltd. trades on the NASDAQ under the ticker symbol "CTHR."

Who are Charles & Colvard, Ltd.'s major shareholders?

Charles & Colvard, Ltd.'s stock is owned by a number of retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (5.10%), Dimensional Fund Advisors LP (0.57%), BlackRock Inc. (0.40%) and Two Sigma Advisers LP (0.28%). Insiders that own company stock include Clint J Pete, Don O'connell, Neal I Goldman and Ollin B Sykes.
View institutional ownership trends
.

How do I buy shares of Charles & Colvard, Ltd.?

Shares of CTHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Charles & Colvard, Ltd.'s stock price today?

One share of CTHR stock can currently be purchased for approximately $0.88.

How much money does Charles & Colvard, Ltd. make?

Charles & Colvard, Ltd. (NASDAQ:CTHR) has a market capitalization of $26.70 million and generates $43.09 million in revenue each year. The company earns $2.37 million in net income (profit) each year or $0.02 on an earnings per share basis.

How can I contact Charles & Colvard, Ltd.?

Charles & Colvard, Ltd.'s mailing address is 170 SOUTHPORT DRIVE, MORRISVILLE NC, 27560. The official website for the company is www.charlesandcolvard.com. The company can be reached via phone at (919) 468-0399, via email at ir@charlesandcolvard.com, or via fax at 919-468-0486.

This page (NASDAQ:CTHR) was last updated on 12/7/2022 by MarketBeat.com Staff